Categories
Stocks News Business News Global News Market News Earnings News IPO News
Quick Links
Ongoing IPO's Upcoming IPO's Closed IPO's Research Call's

shareholder communication

  1. H

    Sebi Confirms Investigation into Par Drugs' Slump Sale

    Sebi Confirms Restrictions on Par Drugs’ Proposed Slump Sale Regulatory Action Pending Investigation New Delhi, March 26 – The Securities and Exchange Board of India (Sebi) has confirmed its previous directions against Par Drugs and Chemicals Ltd (PDCL) regarding a proposed slump sale of its...
    • Himanshu
    • Thread
    • business transfer financial transactions india investigation par drugs and chemicals ltd pdcl phal-jig fine chemicals pvt ltd pjfcpl regulatory compliance sebi securities and exchange board of india shareholder communication slump sale vadodara valuation
    • Replies: 0
    • Forum: Business
Back
Top